Hospitals that don’t report PAMA Private Payer Clinical Laboratory Test Price Data could face hefty penalties
Starting next January, health systems will be required to report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) or risk having to pay as much as $10,000 per day. Yet, according to recent survey results, most health system CEOs and CFOs are not aware of the rule said clinical laboratory and anatomic pathology group management organization DARK Daily in a news release on Monday.
The requirement is part of the Protecting Access to Medicare Act of 2014 (PAMA) but 80 percent of respondents from two surveys said they didn’t know that their health systems met CMS’s definition of “applicable laboratory” which makes them legally required to report how much money they received from private health insurance companies for their lab tests. They also must submit test volume and penalties can be issued to providers if the information they submit is incomplete or inaccurate.
“The fact that a majority of hospital CEOs and CFOs remain unaware of the PAMA law’s price reporting requirement means that their hospitals and health networks are exposed to the substantial - but unnecessary risk - of hefty federal penalties,” said Robert L. Michel, Editor-In-Chief of The Dark Report, in the release. “To help these CEOs and CFOs is our full-day workshop, ‘What Every Hospital and Health Network Lab Must Know to Comply with PAMA Private Payer Price Reporting’.”
The 24th Annual Executive War College on Lab and Pathology Management will present a full-day workshop in New Orleans on Thursday, May 2.
